These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10363085)
1. Tumori. Chronotherapy Study Group of the European Organization for Research and Treatment of Cancer. Garufi C; Dogliotti L; Terzoli E; Focan C; Smaaland R; Chollet P; Perpoint B; Lévi F Tumori; 1999; 85(2):149-50. PubMed ID: 10363085 [No Abstract] [Full Text] [Related]
2. Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer. Sandor V Lancet; 1997 Nov; 350(9087):1325-6. PubMed ID: 9357429 [No Abstract] [Full Text] [Related]
4. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group. Giacchetti S; Bjarnason G; Garufi C; Genet D; Iacobelli S; Tampellini M; Smaaland R; Focan C; Coudert B; Humblet Y; Canon JL; Adenis A; Lo Re G; Carvalho C; Schueller J; Anciaux N; Lentz MA; Baron B; Gorlia T; Lévi F; J Clin Oncol; 2006 Aug; 24(22):3562-9. PubMed ID: 16877722 [TBL] [Abstract][Full Text] [Related]
5. Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer? Mayer RJ J Clin Oncol; 2007 Sep; 25(27):4165-7. PubMed ID: 17709796 [No Abstract] [Full Text] [Related]
6. [Future therapeutic prospectives for the treatment of advanced cancer of the colorectum: our experience with oxaliplatin combined with fluorofolates in chronoinfusions]. Bumma C; Montrucchio G; Manzin E; Oletti MV Tumori; 2000; 86(3 Suppl):S26-8. PubMed ID: 10969613 [No Abstract] [Full Text] [Related]
7. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer. Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039 [No Abstract] [Full Text] [Related]
12. Evolution of systemic therapy for metastatic colorectal cancer. Geh JI; Ma YT Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349 [No Abstract] [Full Text] [Related]
13. Old age: biologic versus chronologic. Gelibter AJ; Di Segni S; Zeuli M; Milella M; Ferretti G; Nuzzo C; Cognetti F J Clin Oncol; 2007 Feb; 25(6):e8. PubMed ID: 17308262 [No Abstract] [Full Text] [Related]
14. [January 2004: a month of success with oxaliplatin and hope for patients with colorectal cancer]. Tumori; 2004; 90(1):suppl 28-30. PubMed ID: 15143997 [No Abstract] [Full Text] [Related]
15. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better. Allegra C; George T; Yothers G J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834 [No Abstract] [Full Text] [Related]
16. Oxaliplatin: a welcome addition to our therapeutic armamentarium. Chu E Clin Colorectal Cancer; 2002 Aug; 2(2):72. PubMed ID: 12453318 [No Abstract] [Full Text] [Related]
17. Systemic chemotherapy for metastatic colorectal cancer: reasons to combine. Calvo E Clin Colorectal Cancer; 2002 Nov; 2(3):170-2. PubMed ID: 12482333 [No Abstract] [Full Text] [Related]
18. Oxaliplatin for colorectal cancer in the United States: better late than never. Chau I; Cunningham D J Clin Oncol; 2003 Jun; 21(11):2049-51. PubMed ID: 12775727 [No Abstract] [Full Text] [Related]
19. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer. Fisher MD Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364 [No Abstract] [Full Text] [Related]
20. [Progress of chemotherapy in colorectal cancer]. Komatsu Y Gan To Kagaku Ryoho; 2007 Nov; 34(11):1771-6. PubMed ID: 18064761 [No Abstract] [Full Text] [Related] [Next] [New Search]